Literature DB >> 29936460

Disodium Cromolyn and Anti-podoplanin Antibodies Strongly Inhibit Growth of BHK 21/C13-derived Fibrosarcoma in a Chick Embryo Chorioallantoic Membrane Model.

Anca Maria Cimpean1, Dusan Lalošević2, Vesna Lalošević3, Pavle Banović2, Marius Raica4, Ovidiu Alexandru Mederle4.   

Abstract

AIM: To characterize baby hamster kidney fibroblast (BHK 21/C13) cells and test the effects of antibodies against podoplanin and disodium cromolyn on BHK 21/C13 cell line-derived tumors grown on chick embryo chorioallantoic membrane (CAM).
MATERIAL AND METHODS: BHK 21/C13 cell-derived fibrosarcomas developed in hamsters were implanted on CAM and treated with anti-podoplanin antibodies and disodium cromolyn. BHK 21/C13 cell immunophenotype was assessed.
RESULTS: Fibrosarcoma cells were positive for vimentin, CD117, smooth muscle actin, vascular endothelial growth factor epidermal growth factor receptor, homebox prospero gene 1 and negative for platelet-derived growth factor B, neuron-specific enolase, S100, CD34, Ewing sarcoma and podoplanin. CAM-grown fibrosarcomas were highly sensitive to disodium cromolyn and anti-podoplanin antibodies.
CONCLUSION: Immunophenotyping BHK 21/C13 cells and their response to drugs represent the first step in revealing cell line utility and a reliable tool for experimental cancer research. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  BHK 21/C13 cell line; chick embryo chorioallantoic membrane; experimental therapy; phenotype characterization

Mesh:

Substances:

Year:  2018        PMID: 29936460      PMCID: PMC6117765          DOI: 10.21873/invivo.11309

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  38 in total

1.  Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.

Authors:  Deng-wei Wu; Fei Mao; Yan Ye; Jian Li; Chuan-lian Xu; Xiao-min Luo; Jing Chen; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2015-08-17       Impact factor: 6.150

2.  Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.

Authors:  Markku Miettinen; Zeng-Feng Wang
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

3.  PROX1 expression in gastric cancer: from hypothesis to evidence.

Authors:  Oana Taban; Anca Maria Cimpean; Marius Raica; Sorin Olariu
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

4.  Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.

Authors:  Kang-Jin Park; Sung-Bum Cho; Young-Lan Park; Nuri Kim; Sun-Young Park; Dae-Seong Myung; Wan-Sik Lee; Sun-Seog Kweon; Young-Eun Joo
Journal:  Gastric Cancer       Date:  2016-01-12       Impact factor: 7.370

5.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

6.  A pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model.

Authors:  Hyuna Lee; Dae Shik Kim; Sang Keun Ha; Inwook Choi; Jong Min Lee; Jong Hwan Sung
Journal:  Biotechnol Bioeng       Date:  2016-09-14       Impact factor: 4.530

7.  Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivo.

Authors:  Wenhong Ren; Borys Korchin; Quan-Sheng Zhu; Caimiao Wei; Adam Dicker; John Heymach; Alexander Lazar; Raphael E Pollock; Dina Lev
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

8.  Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells.

Authors:  Aki Hanyu; Kiyotsugu Kojima; Kiyohiko Hatake; Kimie Nomura; Hironori Murayama; Yuichi Ishikawa; Satoshi Miyata; Masaru Ushijima; Masaaki Matsuura; Etsuro Ogata; Keiji Miyazawa; Takeshi Imamura
Journal:  Cancer Sci       Date:  2009-08-03       Impact factor: 6.716

9.  The role of three cytoplasmic fibers in BHK-21 cell motility. I. Microtubules and the effects of colchicine.

Authors:  R D Goldman
Journal:  J Cell Biol       Date:  1971-12       Impact factor: 10.539

10.  PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.

Authors:  Kapo Saukkonen; Jaana Hagström; Harri Mustonen; Anne Juuti; Stig Nordling; Pauliina Kallio; Kari Alitalo; Hanna Seppänen; Caj Haglund
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

View more
  3 in total

1.  Diagnostic Algorithm in Hirschsprung's Disease: Focus on Immunohistochemistry Markers.

Authors:  Przemyslaw Galazka; Lukasz Szylberg; Magdalena Bodnar; Jan Styczynski; Andrzej Marszalek
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Sarcoma treatment in the era of molecular medicine.

Authors:  Thomas Gp Grünewald; Marta Alonso; Sofia Avnet; Ana Banito; Stefan Burdach; Florencia Cidre-Aranaz; Gemma Di Pompo; Martin Distel; Heathcliff Dorado-Garcia; Javier Garcia-Castro; Laura González-González; Agamemnon E Grigoriadis; Merve Kasan; Christian Koelsche; Manuela Krumbholz; Fernando Lecanda; Silvia Lemma; Dario L Longo; Claudia Madrigal-Esquivel; Álvaro Morales-Molina; Julian Musa; Shunya Ohmura; Benjamin Ory; Miguel Pereira-Silva; Francesca Perut; Rene Rodriguez; Carolin Seeling; Nada Al Shaaili; Shabnam Shaabani; Kristina Shiavone; Snehadri Sinha; Eleni M Tomazou; Marcel Trautmann; Maria Vela; Yvonne Mh Versleijen-Jonkers; Julia Visgauss; Marta Zalacain; Sebastian J Schober; Andrej Lissat; William R English; Nicola Baldini; Dominique Heymann
Journal:  EMBO Mol Med       Date:  2020-10-13       Impact factor: 12.137

3.  Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522.

Authors:  Hong-Gang Qian; Qiong Wu; Jian-Hui Wu; Xiu-Yun Tian; Wei Xu; Chun-Yi Hao
Journal:  Mol Med Rep       Date:  2022-01-11       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.